Letter

Save the FDA

BMJ 2005; 330 doi: 10.1136/bmj.330.7486.308 (Published 3 February 2005)
Cite this as: BMJ 2005;330:308.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Alexander S D Spiers, retired professor of medicine (spiersuk@btinternet.com)
  1. Cookham Dean, Berkshire

    EDITOR—Abbasi asks whether drug regulation is failing.1 The US Food and Drug Administration (FDA) performs a thankless task. Patients want new drugs available immediately and agitate to accomplish this. Patients also wish medicines to be guaranteed safe, and blame the FDA when toxicity leads to a drug's withdrawal. Clinical scientists complain that the FDA obstructs their …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular